PETER BARTON HUTT - 14 Oct 2022 Form 4 Insider Report for CONCERT PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Oct 2022
Net transactions value
-$11,360
Form type
4
Filing time
18 Oct 2022, 16:25:25 UTC
Previous filing
13 Jun 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNCE Common Stock Options Exercise $10,192 +3,539 +12% $2.88 33,027 14 Oct 2022 Direct
transaction CNCE Common Stock Sale $21,553 -3,539 -11% $6.09 29,488 14 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNCE Stock Option (right to buy) Options Exercise $0 -3,539 -100% $0.000000* 0 14 Oct 2022 Common Stock 3,539 $2.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested.